Hereditary Neuroblastoma Research

1 - 1 of 1

Treating Neuroblastoma with Crizotinib

Neuroblastoma treatment is advanced through a study of ALK mutation sensitivities to the anti-cancer drug crizotinib. Drs. Mossé and Mark Lemmon were study co-leaders.